Partnerships in Therapeutics Development

The process of bringing new therapeutic goods to market and to patients is all about partnerships – ARCS has collaborated closely with the TGA, the PEB and the PBAC, government departments and research networks in the development of two exciting Congress programs for 2010. Both programs are available here – read carefully before making your decisions - register NOW to take advantage of Earlybird and Group discounts.
Register

Sydney 2012 full programme now out!

February 2nd, 2012

In 2012, we return to Darling Harbour for our biggest Congress of the year.

This is again set to be the premier Congress for new medicines and devices this year! We have continued to increase the breadth of offerings with streams of content for Clinical Research (Australia and Asia), Study Coordinators and Data Managers, Medical Affairs, Pharmacovigilance, Medical Writing, and Management. Come along and hear over 90 speakers in 31 sessions over the 2 days!! 

Click here to view the full programme. 

To register click here

We look forward to welcoming you at the congress!

Sydney Highlights

  • HIGHLIGHTS coming soon.

Sydney Sponsors

Gold

Silver

Bronze

Register

Leadership Forum News

June 16th, 2011

Details for the 2012 ARCS Leadership Forum are coming soon.

Stay tuned!!

Leadership Forum Highlights

  • More information coming soon

Sponsors

Gold

Silver

Bronze

Register

Canberra Congress

February 21st, 2012

ARCS Scientific Congress, 27th – 28th September 2012

National Convention Centre, Canberra

CALL FOR ABSTRACTS

 

We wish to invite all interested parties from Industry and Government to consider submitting abstract(s) for the Canberra ARCS Scientific Congress. This year ARCS will be running a combined Canberra Congress for those working in Regulatory Affairs, Quality/GMP, Reimbursement and Pharmacovigilance.

Abstracts are sought from general areas of interest covering all therapeutic products including Prescription, OTC and Complementary Medicines, IVDs, Medical Devices and Biologicals.

More

2011 Highlights

  • A focus on ANZTPA, the vision and next steps for the transition
  • Update on multiple TGA reforms announced or pending
  • Packaging and Labelling changes in New Zealand.
  • A strong devices programme
  • A full GMP/quality programme.
  • Pharmacovigilance and Post-Market accountabilities from a Regulatory perspective.
  • Opportunity to meet with TGA colleagues, from various offices including Scientific Evaluation, Manufacturing Quality, Parliamentary and Strategic Support, Information Management, Product Review, Signal Investigation – Devices and Devices Authorisation.



    • Some of our keynote speakers were:

  • Dr Rohan Hammett, National Manager, TGA
  • Dr Stewart Jessamine, Group Manager, Medsafe, NZ



    • Other International Speakers included:

  • Tor Graberg, Chief Pharmaceutical Inspector, Medical Products Agency, Sweden
  • Michael Arnold, Global Business Process Head, Pfizer
  • And over 13 TGA speakers covering topics relevant to personnel involved in submissions to the department.

    • Canberra Sponsors

    Gold

    Silver

    Bronze

    © Copyright 2012 ARCS Australia